Type 1 diabetes

Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus

Diabetes Obes MetabPublished Randomised crossover trial

Authors' conclusion

URLi showed an accelerated insulin lispro absorption and greater postprandial glucose reduction compared with Humalog in children, adolescents and adults with T1D.

Study context

Population
Children (6–11 years), adolescents (12–17 years) and adults (18–64 years) with T1D; 13 children, 14 adolescents, 15 adults13 children · 14 adolescents · 15 adults
Comparison
Ultra rapid lispro vs Humalog
Methodological detailstwo-period, subject- and investigator-blind, single-dose
  • Two-period
  • Subject- and investigator-blind
  • Single-dose

Primary result

As reported in the abstract

Onset of appearance faster with ultra rapid lispro (URLi) vs Humalog, all age groups (all p < .01)
4-5 min
Early 50% tmax reduced with URLi vs Humalog, all age groups (all p < .01)
7-13 min
Exposure in first 15 min increased with URLi vs Humalog, all age groups (all p < .01)
3.5-6.5-fold
Exposure after 3 h decreased with URLi vs Humalog (p = .02)
37-58%
Duration reduced with URLi vs Humalog, children (p = .006)
56 min
Duration reduced with URLi vs Humalog, adolescents (p = .022)
36 min
1-h postprandial glucose reduced with URLi vs Humalog, children (p = .008)
42 mg/dl
1-h postprandial glucose reduced with URLi vs Humalog, adolescents (p = .195)
19 mg/dl
1-h postprandial glucose reduced with URLi vs Humalog, adults (p = .018)
34 mg/dl
Glucose excursion over 5-h test meal reduced with URLi vs Humalog, children
16%
Glucose excursion over 5-h test meal reduced with URLi vs Humalog, adolescents
9%

Safety

Tolerability

URLi was well tolerated in all age groups

Original publication

Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus. Diabetes Obes Metab. Published 3 May 2023. doi:10.1111/dom.15063

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.